John Stanton Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1800 Patterson Grove Rd, Apex, NC 27502 Phone: 215-510-0541 |
Deanna C Smith, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 126 N Salem St, Suite 201, Apex, NC 27502 Phone: 919-342-5778 Fax: 919-342-4613 |
Caitlin Mckisson Masters, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2030 Laura Duncan Rd, Apex, NC 27523 Phone: 919-809-5310 |
Sarah June Mazeika, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8733 Holly Springs Rd, Apex, NC 27539 Phone: 919-981-6588 |
Nicole Sara Purwin Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 800 W Williams St Ste 231f, Apex, NC 27502 Phone: 919-348-2838 |
Trinity Speech Therapy Pllc Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 2729 Cutleaf Dr, Apex, NC 27539 Phone: 978-235-6260 |
Ms. Stephanie Miller-cook, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2908 Concerto Court, Apex, NC 27539 Phone: 919-363-7585 Fax: 919-303-3939 |
News Archive
Pulmonary hypertension, a deadly form of high blood pressure that develops in the lungs, may be caused by an inflammation-producing molecular pathway that damages the inner lining of blood vessels, according to a new study by researchers at the Stanford University School of Medicine.
Tata Consultancy Services, a leading global IT services, consulting and business solutions organization, announced that it has been designated as a Leader in Worldwide Life Sciences R&D Risk-Based Monitoring by global market intelligence firm, IDC, in the "IDC MarketScape: Worldwide Life Science R&D Risk-Based Monitoring 2015 Vendor Assessment," (doc #HI255628, April 2015) report.
Giving chemotherapy to women with operable breast cancer before they have surgery 'not after' helps physicians pin down the best treatment regimen and can reduce the extent of surgery, according to a new systematic review.
Warner Chilcott plc (Nasdaq: WCRX) and LEO Pharma announced today that, in exchange for a one-time cash payment of $1.0 billion to Warner Chilcott, LEO Pharma is re-acquiring Warner Chilcott's exclusive product licensing rights in the United States to its topical psoriasis treatments Taclonex(R), Taclonex Scalp(R), Dovonex(R) as well as rights to all products in LEO's development pipeline, and acquiring all inventories of the products.
A recent study conducted by researchers at Georgia State University is the first of its kind to demonstrate that administration of preemptive morphine prior to a painful procedure in infancy blocks the long-term negative consequences of pain in adult rodents.
› Verified 8 days ago